Dr. Snyder has held several different positions of increasing responsibility in pharmaceutical and parasiticide research and development with Pfizer Animal Health and Elanco Animal Health, with the last 25 years being with Elanco before retiring on 31DEC2017 and establishing a consulting business under a LLC. While at Elanco, he held positions as a lead scientist in discovery research, clinical development of food animal parasiticides, technology acquisitions, and lastly companion animal product development conducting pivotal clinical (laboratory and client owned field studies) effectiveness and field safety studies for submission to global regulatory agencies during his tenure to date. Recent examples include the approval of three successful parasiticides (Comfortis; Trifexis; Credelio) approved by the FDA and other global regulatory agencies for use in dogs and/or cats to control endo- and ectoparasites. Expertise in the practical application of scientific principles and having extensive knowledge of VICH and global regulatory and parasiticide guidelines for the development of veterinary medicines is part of his core expertise. Additionally he is triple board certified, is licensed to practice veterinary medicine in the states of Illinois and Indiana, holds several issued patents, and has published extensively in peer reviewed scientific journals.